W
AZN icon

WealthStone’s AstraZeneca AZN Stock Holding History

WealthStone’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$220K Buy
+2,218
New +$223K 0.08% 231
2020
Q4 		– Sell
-2,080
Closed -$228K – 255
2020
Q3 		$228K Buy
+2,080
New +$231K 0.1% 141
2019
Q3 		– Sell
-63
Closed -$5.16K – 100
2019
Q2 		$5.16K Buy
+63
New +$4.94K ﹤0.01% 339

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WealthStone's AZN Position: Q1 2021 in Review

WealthStone opened a new position in AstraZeneca (AZN) in Q1 2021: 2,218 shares worth $220K. The stake represents 0.08% of the portfolio and ranks #231 among its holdings. This is a return to the name: WealthStone previously reported a position in AZN as recently as Q3 2020.

WealthStone first reported a position in AZN in Q2 2019 and has held it in 3 quarters since. The position peaked at $228K in Q3 2020. 755 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

  • WealthStone held 2,218 shares of AstraZeneca worth $220K as of Q1 2021.
  • AstraZeneca was a new WealthStone position in Q1 2021.
  • AstraZeneca made up 0.08% of WealthStone's portfolio in Q1 2021, its #231 holding.
  • WealthStone first reported a position in AstraZeneca in Q2 2019 and has held it in 3 quarters since.
  • WealthStone's AstraZeneca position peaked at $228K in Q3 2020.
  • 755 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.